{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:01:08Z","timestamp":1791489668265,"version":"4.3.4"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2011,12,21]],"date-time":"2011-12-21T00:00:00Z","timestamp":1324425600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1007\/s00535-011-0519-2","type":"journal-article","created":{"date-parts":[[2011,12,20]],"date-time":"2011-12-20T03:08:09Z","timestamp":1324350489000},"page":"569-576","source":"Crossref","is-referenced-by-count":37,"title":["Risk factors for hepatocellular carcinoma in Japanese patients with autoimmune hepatitis type 1"],"prefix":"10.1007","volume":"47","author":[{"name":"Autoimmune Hepatitis Study Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruko","family":"Hino-Arinaga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Ide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoko","family":"Kuromatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Miyajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Ogata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiichiro","family":"Kuwahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Hisamochi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuji","family":"Torimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michio","family":"Sata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,12,21]]},"reference":[{"key":"519_CR1","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1053\/gast.1996.v110.pm8608895","volume":"110","author":"SK Roberts","year":"1996","unstructured":"Roberts SK, Therneau TM, Czaja AJ. Prognosis of histological cirrhosis in type 1 autoimmune hepatitis. Gastroenterology. 1996;110:848\u201357.","journal-title":"Gastroenterology"},{"key":"519_CR2","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/S0168-8278(97)80453-9","volume":"26","author":"G Toda","year":"1997","unstructured":"Toda G, Zeniya M, Watanabe F, Imawari M, Kiyosawa K, Nishioka M, et al. Present status of autoimmune hepatitis in Japan\u2013correlating the characteristics with international criteria in an area with a high rate of HCV infection. Japanese National Study Group of Autoimmune Hepatitis. J Hapetol. 1997;26:1207\u201312.","journal-title":"J Hapetol"},{"key":"519_CR3","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1055\/s-2002-35706","volume":"22","author":"AJ Czaja","year":"2002","unstructured":"Czaja AJ. Treatment of autoimmune hepatitis. Semin Liver Dis. 2002;22:365\u201378.","journal-title":"Semin Liver Dis"},{"key":"519_CR4","first-page":"749","volume":"11","author":"T Hino","year":"2003","unstructured":"Hino T, Kumashiro R, Ide T, Koga Y, Ishii K, Tanaka E, et al. Predictive factors for remission and death in 73 patients with autoimmune hepatitis in Japan. Int J Mol Med. 2003;11:749\u201355.","journal-title":"Int J Mol Med"},{"key":"519_CR5","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1002\/hep.1840080635","volume":"8","author":"KK Wang","year":"1988","unstructured":"Wang KK, Czaja AJ. Hepatocellular carcinoma in corticosteroid-treated severe autoimmune chronic active hepatitis. Hepatology. 1988;8:1679\u201383.","journal-title":"Hepatology"},{"key":"519_CR6","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1440-1746.1992.tb00938.x","volume":"7","author":"M Yousuf","year":"1992","unstructured":"Yousuf M, Kiyosawa K, Sodeyama T, Yoda H, Nakano Y, Furuta S. Development of hepatocellular carcinoma in a man with auto-immune chronic active hepatitis. J Gastroenterol Hepatol. 1992;7:66\u20139.","journal-title":"J Gastroenterol Hepatol"},{"key":"519_CR7","first-page":"718","volume":"22","author":"SD Ryder","year":"1995","unstructured":"Ryder SD, Koskinas J, Rizzi PM, McFarlane IG, Portmann BC, Naoumov NV, et al. Hepatocellular carcinoma complicating autoimmune hepatitis: role of hepatitis C virus. Hepatology. 1995;22:718\u201322.","journal-title":"Hepatology"},{"key":"519_CR8","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1023\/A:1005638500236","volume":"45","author":"SZ Park","year":"2000","unstructured":"Park SZ, Nagorney DM, Czaja AZ. Hepatocellular carcinoma in autoimmune hepatitis. Dig Dis Sci. 2000;45:1944\u20138.","journal-title":"Dig Dis Sci"},{"key":"519_CR9","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00534-003-0878-z","volume":"11","author":"R Nishiyama","year":"2004","unstructured":"Nishiyama R, Kanai T, Abe J, Hara R, Watahiki Y, Sakaguchi T, et al. Hepatocellular carcinoma associated with autoimmune hepatitis. J Hepatobiliary Pancreat Surg. 2004;11:215\u20139.","journal-title":"J Hepatobiliary Pancreat Surg"},{"key":"519_CR10","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1007\/s00595-007-3483-y","volume":"37","author":"H Okino","year":"2007","unstructured":"Okino H, Satoh T, Watanabe J, Masumoto A, Takeda S. Hepatocellular carcinoma arising from autoimmune hepatitis: report of a case. Surg Today. 2007;37:716\u20138.","journal-title":"Surg Today"},{"key":"519_CR11","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/hep.22432","volume":"48","author":"AD Yeoman","year":"2008","unstructured":"Yeoman AD, Al-Chalabi T, Karani JB, Quaglia A, Devlin J, Mieli-Vergani G, et al. Evaluation of risk factors in the development of hepatocellular carcinoma in autoimmune hepatitis: implications for follow-up and screening. Hepatology. 2008;48:863\u201370.","journal-title":"Hepatology"},{"key":"519_CR12","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1111\/j.1572-0241.2008.01922.x","volume":"103","author":"AJ Montano-Loza","year":"2008","unstructured":"Montano-Loza AJ, Carpenter HA, Czaja AJ. Predictive factors for hepatocellular carcinoma in type 1 autoimmune hepatitis. Am J Gastroenterol. 2008;103:1944\u201351.","journal-title":"Am J Gastroenterol"},{"key":"519_CR13","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jhep.2008.08.022","volume":"50","author":"M Werner","year":"2009","unstructured":"Werner M, Almer S, Prytz H, Lindgren S, Wallerstedt S, Bj\u00f6rnsson E, et al. Hepatic and extrahepatic malignancies in autoimmune hepatitis. A long-term follow-up in 473 Swedish patients. J Hepatol. 2009;50:388\u201393.","journal-title":"J Hepatol"},{"key":"519_CR14","doi-asserted-by":"crossref","first-page":"578","DOI":"10.3748\/wjg.15.578","volume":"15","author":"A Teufel","year":"2009","unstructured":"Teufel A, Weinmann A, Centner C, Piendl A, Lohse AW, Galle PR, et al. Hepatocellular carcinoma in patients with autoimmune hepatitis. World J Gastroenterol. 2009;15:578\u201382.","journal-title":"World J Gastroenterol"},{"key":"519_CR15","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1002\/hep.1840180435","volume":"18","author":"P Johnson","year":"1993","unstructured":"Johnson P, McFarlane I. Meeting report: International Autoimmune Hepatitis Group. Hepatology. 1993;18:993\u20131005.","journal-title":"Hepatology"},{"key":"519_CR16","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMoa021423","volume":"348","author":"EE Calle","year":"2003","unstructured":"Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med. 2003;348:1625\u201338.","journal-title":"N Engl J Med"},{"key":"519_CR17","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1111\/j.1572-0241.2001.04054.x","volume":"96","author":"HB El-Serag","year":"2001","unstructured":"El-Serag HB, Richardson PA, Everhart JE. The role of diabetes in hepatocellular carcinoma: a case\u2013control study among United States Veterans. Am J Gastroenterol. 2001;96:2462\u20137.","journal-title":"Am J Gastroenterol"},{"key":"519_CR18","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1002\/lt.20033","volume":"10","author":"JM Regimbeau","year":"2004","unstructured":"Regimbeau JM, Colombat M, Mognol P, Durand F, Abdalla E, Degott C, et al. Obesity and diabetes as a risk factor for hepatocellular carcinoma. Liver Transpl. 2004;10:S69\u201373.","journal-title":"Liver Transpl"},{"key":"519_CR19","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1136\/gut.2004.052167","volume":"54","author":"JA Davila","year":"2005","unstructured":"Davila JA, Morgan RO, Shaib Y, McGlynn KA, El-Serag HB. Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study. Gut. 2005;54:533\u20139.","journal-title":"Gut"},{"key":"519_CR20","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1053\/gast.2002.34168","volume":"123","author":"E Bugianesi","year":"2002","unstructured":"Bugianesi E, Leone N, Vanni E, Marchesini G, Brunello F, Carucci P, et al. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology. 2002;123:134\u201340.","journal-title":"Gastroenterology"},{"key":"519_CR21","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1053\/jhep.2002.36939","volume":"36","author":"JA Marrero","year":"2002","unstructured":"Marrero JA, Fontana RJ, Su GL, Conjeevaram HS, Emick DM, Lok AS. NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States. Hepatology. 2002;36:1349\u201354.","journal-title":"Hepatology"},{"key":"519_CR22","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00535-003-1308-3","volume":"39","author":"S Mori","year":"2004","unstructured":"Mori S, Yamasaki T, Sakaida I, Takami T, Sakaguchi E, Kimura T, et al. Hepatocellular carcinoma with nonalcoholic steatohepatitis. J Gastroenterol. 2004;39:391\u20136.","journal-title":"J Gastroenterol"},{"key":"519_CR23","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/annonc\/mdn565","volume":"20","author":"J Polesel","year":"2009","unstructured":"Polesel J, Zucchetto A, Montella M, Dal Maso L, Crispo A, La Vecchia C, et al. The impact of obesity and diabetes mellitus on the risk of hepatocellular carcinoma. Ann Oncol. 2009;20:353\u20137.","journal-title":"Ann Oncol"},{"key":"519_CR24","first-page":"465","volume":"8","author":"C Gao","year":"2009","unstructured":"Gao C, Yao SK. Diabetes mellitus: a \u201ctrue\u201d independent risk factor for hepatocellular carcinoma? Hepatobiliary Pancreat Dis Int. 2009;8:465\u201373.","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"519_CR25","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","volume":"31","author":"F Alvarez","year":"1999","unstructured":"Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999;31:929\u201338.","journal-title":"J Hepatol"},{"key":"519_CR26","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0168-8227(01)00365-5","volume":"55","author":"T Kuzuya","year":"2002","unstructured":"Kuzuya T, Nakagawa S, Satoh J, Kanazawa Y, Iwamoto Y, Kobayashi M, et al. Committee of the Japan Diabetes Society on the diagnostic criteria of diabetes mellitus. Report of the committee on the classification and diagnostic criteria of diabetes mellitus. Diabetes Res Clin Pract. 2002;55:65\u201385.","journal-title":"Diabetes Res Clin Pract"},{"key":"519_CR27","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/hep.1840190629","volume":"19","author":"VJ Desmet","year":"1994","unstructured":"Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology. 1994;19:1513\u201320.","journal-title":"Hepatology"},{"key":"519_CR28","unstructured":"Group formed to establish the guidelines for evidence-based clinical practice for the treatment of liver cancer. Clinical practice guidelines for hepatocellular carcinoma. Tokyo: Kanehara & Co.; 2005."},{"key":"519_CR29","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1159\/000111702","volume":"72","author":"M Kudo","year":"2007","unstructured":"Kudo M, Okanoue T. Management of hepatocellular carcinoma in Japan: consensus-based clinical practice manual proposed by the Japan Society of Hepatology. Oncology. 2007;72:S2\u201315.","journal-title":"Oncology"},{"key":"519_CR30","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1093\/rheumatology\/35.8.738","volume":"35","author":"M Jones","year":"1996","unstructured":"Jones M, Symmons D, Finn J, Wolfe F. Does exposure to immunosuppressive therapy increase the 10\u00a0years malignancy and mortality risks in rheumatoid arthritis? A matched cohort study. Br J Rheumatol. 1996;35:738\u201345.","journal-title":"Br J Rheumatol"},{"key":"519_CR31","first-page":"1705","volume":"26","author":"P Asten","year":"1999","unstructured":"Asten P, Barrett J, Symmons D. Risk of developing certain malignancies is related to duration of immunosuppressive drug exposure in patients with rheumatic diseases. J Rheumatol. 1999;26:1705\u201314.","journal-title":"J Rheumatol"},{"key":"519_CR32","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1001\/archinternmed.2007.107","volume":"168","author":"S Bernatsky","year":"2008","unstructured":"Bernatsky S, Clarke AE, Suissa S. Hematologic malignant neoplasms after drug exposure in rheumatoid arthritis. Arch Intern Med. 2008;168:378\u201381.","journal-title":"Arch Intern Med"},{"key":"519_CR33","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/art.21675","volume":"54","author":"E Baecklund","year":"2006","unstructured":"Baecklund E, Iliadou A, Askling J, Ekbom A, Backlin C, Granath F, et al. Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis. Arthritis Rheum. 2006;54:692\u2013701.","journal-title":"Arthritis Rheum"},{"key":"519_CR34","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1111\/j.1365-2036.2006.03113.x","volume":"24","author":"Y Miyake","year":"2006","unstructured":"Miyake Y, Iwasaki Y, Terada R, Okamoto R, Ikeda H, Makino Y, et al. Persistent elevation of serum alanine aminotransferase levels leads to poor survival and hepatocellular carcinoma development in type 1 autoimmune hepatitis. Aliment Pharmacol Ther. 2006;24:1197\u2013205.","journal-title":"Aliment Pharmacol Ther"},{"key":"519_CR35","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/hep.23584","volume":"51","author":"MP Manns","year":"2010","unstructured":"Manns MP, Czaja AJ, Gorham JD, Krawitt EL, Mieli-Vergani G, Vergani D, et al. American Association for the Study of Liver Diseases. Diagnosis and management of autoimmune hepatitis. Hepatology. 2010;51:2193\u2013213.","journal-title":"Hepatology"},{"key":"519_CR36","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1053\/jhep.2002.34944","volume":"36","author":"A Czaja","year":"2002","unstructured":"Czaja A, Freese D. Diagnosis and treatment of autoimmune hepatitis. Hepatology. 2002;36:479\u201397.","journal-title":"Hepatology"},{"key":"519_CR37","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jhep.2010.01.037","volume":"53","author":"MM Lamers","year":"2010","unstructured":"Lamers MM, van Oijen MG, Pronk M, Drenth JP. Treatment options for autoimmune hepatitis: a systematic review of randomized controlled trials. J Hepatol. 2010;53:191\u20138.","journal-title":"J Hepatol"},{"key":"519_CR38","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1007\/s12072-009-9155-9","volume":"3","author":"Y Miyake","year":"2009","unstructured":"Miyake Y, Iwasaki Y, Kobashi H, Yasunaka T, Ikeda F, Takaki A, et al. Efficacy of ursodeoxycholic acid for Japanese patients with autoimmune hepatitis. Hepatol Int. 2009;3:556\u201362.","journal-title":"Hepatol Int"},{"key":"519_CR39","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1440-1746.1998.tb00674.x","volume":"13","author":"K Nakamura","year":"1998","unstructured":"Nakamura K, Yoneda M, Yokohama S, Tomori K, Sato Y, Aso K, et al. Efficacy of ursodeoxycholic acid in Japanese patients with type 1 autoimmune hepatitis. J Gastroenterol Hepatol. 1998;13:490\u20135.","journal-title":"J Gastroenterol Hepatol"},{"key":"519_CR40","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.hepres.2006.06.007","volume":"36","author":"T Miyake","year":"2006","unstructured":"Miyake T, Miyaoka H, Abe M, Furukawa S, Shigematsu S, Furukawa E, et al. Clinical characteristics of autoimmune hepatitis in older aged patients. Hepatol Res. 2006;36:139\u201342.","journal-title":"Hepatol Res"},{"key":"519_CR41","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s00535-008-2251-0","volume":"44","author":"T Umemura","year":"2009","unstructured":"Umemura T, Ichijo T, Yoshizawa K, Tanaka E, Kiyosawa K. Epidemiology of hepatocellular carcinoma in Japan. J Gastroenterol. 2009;44:102\u20137.","journal-title":"J Gastroenterol"},{"key":"519_CR42","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1023\/A:1014715327729","volume":"47","author":"J Tazawa","year":"2002","unstructured":"Tazawa J, Maeda M, Nakagawa M, Ohbayashi H, Kusano F, Yamane M, et al. Diabetes mellitus may be associated with hepatocarcinogenesis in patients with chronic hepatitis C. Dig Dis Sci. 2002;47:710\u20135.","journal-title":"Dig Dis Sci"},{"key":"519_CR43","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1002\/hep.22251","volume":"47","author":"BJ Veldt","year":"2008","unstructured":"Veldt BJ, Chen W, Heathcote EJ, Wedemeyer H, Reichen J, Hofmann WP, et al. Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus. Hepatology. 2008;47:1856\u201362.","journal-title":"Hepatology"},{"key":"519_CR44","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1872-034X.2007.00077.x","volume":"37","author":"Y Torisu","year":"2007","unstructured":"Torisu Y, Ikeda K, Kobayashi M, Hosaka T, Sezaki H, Akuta N, et al. Diabetes mellitus increases the risk of hepatocarcinogenesis in patients with alcoholic cirrhosis: a preliminary report. Hepatol Res. 2007;37:517\u201323.","journal-title":"Hepatol Res"},{"key":"519_CR45","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1053\/j.gastro.2004.09.014","volume":"127","author":"G Fattovich","year":"2004","unstructured":"Fattovich G, Stroffolini T, Zagni I, Donato F. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology. 2004;127:S35\u201350.","journal-title":"Gastroenterology"},{"key":"519_CR46","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1053\/j.gastro.2007.04.061","volume":"132","author":"HB El-Serag","year":"2007","unstructured":"El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007;132:2557\u201376.","journal-title":"Gastroenterology"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-011-0519-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00535-011-0519-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-011-0519-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T22:37:58Z","timestamp":1559083078000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00535-011-0519-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,21]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["519"],"URL":"https:\/\/doi.org\/10.1007\/s00535-011-0519-2","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,21]]}}}